Recent case-series of small size implied a pathophysiological association between
coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given …

Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness …

Background The risk of recurrent stroke is up to 10% in the week after a transient ischaemic
attack (TIA) or minor stroke. Modelling studies suggest that urgent use of existing preventive …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, is associated with coagulopathy causing venous and …

Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims
through automated image pattern recognition. For neurological disorders, this includes …

Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disease with
heterogeneous clinicopathological manifestations and is a well-established cause of acute …

Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …

Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Background and Purpose—Most guidelines now recommend that patients with minor stroke
or high-risk transient ischemic attack (TIA) are assessed within 24 hours of their event, but …

Objective: Many guidelines recommend emergency assessment for patients with≥ 2 TIAs
within 7 days, perhaps in recognition of the capsular warning syndrome. However, it is …